Myriad Genetics buy Raymond James
Start price
25.02.25
/
50%
€11.40
Target price
25.02.26
€18.10
Performance (%)
-65.44%
End price
26.02.26
€3.94
Summary
This prediction ended on 26.02.26 with a price of €3.94. Massive losses of -65.44% were the result for the BUY prediction by Raymond_James. Raymond_James has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -8.333% | -8.333% | -46.950% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $19.00 price target on the stock, down previously from $27.00.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten